Overview
Yiwen Cao practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Nephrotic Syndrome, IgA Nephropathy, Glomerulonephritis, and Chronic Kidney Disease.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yiwen Cao
Is Yiwen Cao a top-rated expert for Nephrotic Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Yiwen Cao is classified as an Experienced expert for Nephrotic Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yiwen Cao participate in research or clinical trials?
Yes. Yiwen Cao has published 14 articles and abstracts on conditions like Nephrotic Syndrome. You can view a list of Yiwen Cao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Kidney DiseaseCao isExperienced. Learn about Chronic Kidney Disease.
- GlomerulonephritisCao isExperienced. Learn about Glomerulonephritis.
- IgA NephropathyCao isExperienced. Learn about IgA Nephropathy.
- Nephrotic SyndromeCao isExperienced. Learn about Nephrotic Syndrome.